An Endogenous Inhibitor of Human Immunodeficiency Virus in Human Lymphocytes Is Overcome by the Viral Vif Protein

ABSTRACT The vif gene of human immunodeficiency virus type 1 (HIV-1) encodes a basic M r 23,000 protein that is necessary for production of infectious virions by nonpermissive cells (human lymphocytes and macrophages) but not by permissive cells such as HeLa-CD4. It had been proposed that permissive cells may contain an unidentified factor that functions like the viral Vif protein. To test this hypothesis, we produced pseudotyped wild-type andvif-deleted HIV gpt virions (which contain the HIV-1 genome with the bacterial mycophenolic acid resistance genegpt in place of the viral env gene) in permissive cells, and we used them to generate nonpermissive H9 leukemic T cells that express these proviruses. We then fused these H9 cells with permissive HeLa cells that express the HIV-1 envelope glycoprotein gp120-gp41, and we asked whether the heterokaryons would release infectious HIV gpt virions. The results clearly showed that the vif-deleted virions released by the heterokaryons were noninfectious whereas the wild-type virions were highly infectious. This strongly suggests that nonpermissive cells, the natural targets of HIV-1, contain a potent endogenous inhibitor of HIV-1 replication that is overcome by Vif.

[1]  J. Kappes,et al.  The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures , 1995, Journal of virology.

[2]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[3]  B. Chesebro,et al.  Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1 , 1994, Journal of virology.

[4]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[5]  P. Sova,et al.  The human immunodeficiency virus type 1 vif gene: the road from an accessory to an essential role in human immunodeficiency virus type 1 replication. , 1995, Current topics in microbiology and immunology.

[6]  J. Orenstein,et al.  Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1 , 1995, Journal of virology.

[7]  F. Rey,et al.  Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps , 1995, Journal of virology.

[8]  D. Kabat,et al.  Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor , 1997, Journal of virology.

[9]  H. Ploegh.  Viral strategies of immune evasion. , 1998, Science.

[10]  R. Weiss,et al.  Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle. , 1993, Virology.

[11]  D. Littman,et al.  Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity , 1990, Journal of virology.

[12]  C. Dauguet,et al.  Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity , 1995, Journal of virology.

[13]  M. Malim,et al.  The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross‐species transmission , 1998, The EMBO journal.

[14]  P. Jallepalli,et al.  Subcellular localization of the Vif protein of human immunodeficiency virus type 1 , 1994, Journal of virology.

[15]  D. Baltimore,et al.  CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef , 1996, Journal of virology.

[16]  F. Rey,et al.  Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells , 1997, Journal of virology.

[17]  D. Trono,et al.  HIV accessory proteins: Leading roles for the supporting cast , 1995, Cell.

[18]  K. Strebel,et al.  Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein , 1996, Journal of virology.

[19]  M. Malim,et al.  Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins , 1996, Journal of virology.

[20]  David C. Johnson,et al.  Infected Cell Protein (ICP)47 Enhances Herpes Simplex Virus Neurovirulence by Blocking the CD8+ T Cell Response , 1998, The Journal of experimental medicine.

[21]  A. Adachi,et al.  Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles , 1993, Journal of virology.

[22]  H. Robinson,et al.  Context-dependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers , 1993, Journal of virology.

[23]  J. McDougall,et al.  Telomerase activation by the E6 gene product of human papillomavirus type 16 , 1996, Nature.

[24]  J. Sodroski,et al.  Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes , 1992, Journal of virology.

[25]  D. Trono,et al.  Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells , 1993, Journal of virology.